Company

X4 Pharmaceuticals, Inc

XFOR · CIK 0001501697

SEC FORM 4

$210,829.30

Sale of 47,436 shares at $4.4445 per share.

Reporting Person Craig Adam R · Officer Title Executive Chairman · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001501697-26-000069 · filed 2026-08-13 · View filing →

SEC FORM 4

$109,228.03

Sale of 24,576 shares at $4.4445 per share.

Reporting Person Volpone John · Officer Title President · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001501697-26-000070 · filed 2026-08-13 · View filing →